# Matteo Monami

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/matteo-monami/

## Facts

| Field | Value |
| --- | --- |
| Citations | 14,228 |
| Field | Diabetes Treatment and Management |
| h-index | 63 |
| i10-index | 213 |
| Last Known Institution | Azienda Ospedaliero-Universitaria Careggi |
| OpenAlex ID | https://openalex.org/A5059413618 |
| ORCID iD | 0000-0001-9349-828X |
| Works | 363 |

## Researcher papers

- [Hypogonadism as a risk factor for cardiovascular mortality in men: a meta-analytic study](https://scholariq.org/papers/hypogonadism-as-a-risk-factor-for-cardiovascular-mortality-in-men-a-meta/)
- [Body weight loss reverts obesity-associated hypogonadotropic hypogonadism: a systematic review and meta-analysis](https://scholariq.org/papers/body-weight-loss-reverts-obesity-associated-hypogonadotropic-hypogonadism-a/)
- [Testosterone and Metabolic Syndrome: A Meta-Analysis Study](https://scholariq.org/papers/testosterone-and-metabolic-syndrome-a-meta-analysis-study/)
- [Type 2 diabetes mellitus and testosterone: a meta-analysis study](https://scholariq.org/papers/type-2-diabetes-mellitus-and-testosterone-a-meta-analysis-study/)
- [Effect of metformin on cardiovascular events and mortality: a meta‐analysis of randomized clinical trials](https://scholariq.org/papers/effect-of-metformin-on-cardiovascular-events-and-mortality-a-meta-analysis-of/)
- [Efficacy and safety of sodium glucose co‐transport‐2 inhibitors in type 2 diabetes: a meta‐analysis of randomized clinical trials](https://scholariq.org/papers/efficacy-and-safety-of-sodium-glucose-co-transport-2-inhibitors-in-type-2/)
- [Dipeptidyl Peptidase-4 Inhibitors and Bone Fractures](https://scholariq.org/papers/dipeptidyl-peptidase-4-inhibitors-and-bone-fractures/)
- [Dipeptidyl peptidase‐4 inhibitors and cardiovascular risk: a meta‐analysis of randomized clinical trials](https://scholariq.org/papers/dipeptidyl-peptidase-4-inhibitors-and-cardiovascular-risk-a-meta-analysis-of/)
- [Cardiovascular safety of sulfonylureas: a meta‐analysis of randomized clinical trials](https://scholariq.org/papers/cardiovascular-safety-of-sulfonylureas-a-meta-analysis-of-randomized-clinical/)
- [Safety issues with glucagon‐like peptide‐1 receptor agonists (pancreatitis, pancreatic cancer and cholelithiasis): <scp>D</scp> ata from randomized controlled trials](https://scholariq.org/papers/safety-issues-with-glucagon-like-peptide-1-receptor-agonists-pancreatitis/)
- [Weight‐reducing treatments are associated with an improvement in depression, functional health status, and quality of life: A meta‐analysis of randomized controlled trials](https://scholariq.org/papers/weight-reducing-treatments-are-associated-with-an-improvement-in-depression/)

## Researcher topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Diabetes Management and Research](https://scholariq.org/topics/diabetes-management-and-research/)
- [Diabetes, Cardiovascular Risks, and Lipoproteins](https://scholariq.org/topics/diabetes-cardiovascular-risks-and-lipoproteins/)
- [Metabolism, Diabetes, and Cancer](https://scholariq.org/topics/metabolism-diabetes-and-cancer/)
- [Diabetic Foot Ulcer Assessment and Management](https://scholariq.org/topics/diabetic-foot-ulcer-assessment-and-management/)

## Researcher university

- [Azienda Ospedaliero-Universitaria Careggi](https://scholariq.org/institutions/azienda-ospedaliero-universitaria-careggi/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.